Jardiance tablets 25mg (YJ_code: 3969023F2020, standard: 25mg 1 tablet) from Nippon Boehringer Ingelheim contains empagliflozin, an SGLT2 inhibitor used to treat type 2 diabetes, heart failure, and chronic kidney disease. It helps kidneys remove sugar from the blood, and reduces the risk of cardiovascular death and hospitalization for heart failure.
Jardiance tablets 25mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →